Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Roszman

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Immunology Today|October 1, 1991
Modulation of T-cell function by gliomasT Roszman, L Elliott, W Brooks
Journal of the National Cancer Institute|May 1, 1987
Role of interleukin-2 (IL-2) and IL-2 receptor expression in the proliferative defect observed in mitogen-stimulated lymphocytes from patients with gliomasL Elliott, W Brooks, T Roszman
Cellular and Molecular Neurobiology|October 1, 1992
Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethasone, isoproterenol, or prostaglandin E2 either alone or in combinationL Elliott, W Brooks, T Roszman
Cellular and Molecular Neurobiology|December 1, 1993
Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation and interleukin-2 secretion by physiologic combinations of dexamethasone and prostaglandin E2L Elliott, W Brooks, T Roszman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 2001
Interstitial nephritis, hepatic failure, and systemic eosinophilia after minocycline treatmentS Kiessling, K Forrest, J Moscow, et al.
Journal of the American Geriatrics Society|April 1, 1984
The immune status of healthy centenariansJ S Thompson, D R Wekstein, J L Rhoades, et al.
Anticancer Research|May 1, 1990
Role of the Ha-ras (RasH) oncogene in mediating progression of the tumor cell phenotype (review)J F Boylan, J Jackson, M R Steiner, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Immunology Today|October 1, 1991
Modulation of T-cell function by gliomasT Roszman, L Elliott, W Brooks
Journal of the National Cancer Institute|May 1, 1987
Role of interleukin-2 (IL-2) and IL-2 receptor expression in the proliferative defect observed in mitogen-stimulated lymphocytes from patients with gliomasL Elliott, W Brooks, T Roszman
Cellular and Molecular Neurobiology|October 1, 1992
Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethasone, isoproterenol, or prostaglandin E2 either alone or in combinationL Elliott, W Brooks, T Roszman
Cellular and Molecular Neurobiology|December 1, 1993
Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation and interleukin-2 secretion by physiologic combinations of dexamethasone and prostaglandin E2L Elliott, W Brooks, T Roszman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 2001
Interstitial nephritis, hepatic failure, and systemic eosinophilia after minocycline treatmentS Kiessling, K Forrest, J Moscow, et al.
Journal of the American Geriatrics Society|April 1, 1984
The immune status of healthy centenariansJ S Thompson, D R Wekstein, J L Rhoades, et al.
Anticancer Research|May 1, 1990
Role of the Ha-ras (RasH) oncogene in mediating progression of the tumor cell phenotype (review)J F Boylan, J Jackson, M R Steiner, et al.
Pageof 1